Ticks and fleas are the primary ectoparasites infesting dogs ([@R9]). *Dermacentor* tick species are present worldwide and can be vectors of disease for humans and animals ([@R1]; [@R8]). In Western Europe, *Dermacentor reticulatus* is a common tick species affecting dogs and is the primary vector of *Babesia canis canis* ([@R2]). Effective control of tick infestations on dogs is based on several strategies, including avoidance of infested environments, environmental controls, and regular application of acaricides to the dog. Environmental control measures are often complex and have varying success rates. Tick infested environments are not easily identifiable; therefore avoidance is not always possible. Thus, regular topical applications of acaricides or combination products (*e.g.* insecticide/acaricide) are often used to control external parasite infestations in domestic animals ([@R3]). Spot-on formulations of insecticides and/or acaricidal drugs provide a convenient method for external parasite control in dogs and cats.

In this study, two topical insecticide/acaricide combination products with labelled activity against ticks were chosen for comparison: the new topical combination fipronil/amitraz/(S)-methoprene in a dual chamber pipette (fipronil 10% w/v and (S)-methoprene 9% w/v in chamber one and amitraz 20% w/v in chamber two; CERTIFECT^®^ Spot-On Dog \[registered trademark of Merial. All other marks are the property of their respective owners\]) and imidacloprid/permethrin in a single chamber pipette (imidacloprid 10% w/v + permethrin 50% w/v; ADVANTIX^®^ \[Europe; Bayer AG\] or K9 ADVANTIX^®^ \[United States; Bayer Animal Health\]).

As a single entity, fipronil provides broad spectrum of activity against insects (including fleas and lice) and acari (including ticks and other mites). The new combination with amitraz was formulated and developed to significantly increase the speed of kill of fipronil on ticks, due to a potentiation effect provided by amitraz ([@R9]; [@R10]). This new spot-on combination has been registered in 2011 in both the USA and Europe. Imidacloprid is an insecticide with no labelled activity against acari; thus, a combination product including permethrin was developed to create a product with a broadened range of efficacy. It is commercialized in the USA and in European countries since a few years.

Tick efficacy guidelines for approval in both EU and USA typically require efficacy ≥ 90% at 48-hour counts ([@R7]). The purpose of the study was to assess the ability of each product to disrupt attachment of ticks and to assess the sustained speed of kill activity at 24-hour counts. Both rapid kill and disruption of attachment of newly acquired ticks would lower the numbers of engorged ticks seen, and potentially reduce the risk of transmission of many tick-borne pathogens. While rapid activity is desirable, it is equally important that rapid activity is sustained throughout the treatment interval. This study assessed the 24-hour activity against weekly infestations of *D. reticulatus* ticks, through Day 36.

Materials and Methods {#S1}
=====================

Study Design {#S2}
------------

This study was a randomized, blinded, negative controlled comparative-efficacy study. All dogs were managed similarly and with due regard for their well-being. All were handled in compliance with local and Merial Institutional Animal Care and Use Committee approvals and in accordance with any applicable laws and regulations. Each dog was individually housed throughout the study.

From a pool of 28 healthy dogs, 24 dogs demonstrating the highest tick counts following a prequalification infestation were selected for use in this study. Dogs were allocated to one of eight replicates of three dogs each based on pre-treatment bodyweight, then the dogs within each replicate were randomly allocated to one of three groups of eight dogs each. Dogs used in this study hadn't been treated with any ectoparasiticides in the preceding three months. Dogs were shampooed seven days prior to treatment with a non-insecticidal shampoo (Purl^®^ Shampoo, registered trademark of Kryon laboratories, South Africa).

Treatments were applied by weight, in accordance with approved-label directions on Day 0. The dogs were weighed to determine appropriate dosing. If the weight of any dog did not fall exactly on a whole pound, their weight was rounded up to the next whole pound. Dogs weighed between 27 and 53 lbs (12.2 to 24 kg).

Dogs in Treatment Group 1 remained untreated.

Dogs in Treatment Group 2 ([Table I](#T1){ref-type="table"}) were treated with the appropriate size of CERTIFECT^®^ Spot-On for dogs (in total volume applied on dogs: fipronil 6.26% w/v, amitraz 7.48% w/v and (S)-methoprene 5.63% w/v). The total volume was applied on the dog's midline; half midway up the neck, half between the shoulder blades. Table I.Dosage of dogs in the treated groups.TreatmentBodyweight range --- lbs (kg)Pipette sizePipette volumes --- mlCertifect^®^ Spot-On for dogs23--44 (10--20)M2.1445--88 (20--40)L4.28Advantix^®^ spot-on for dogs21--55 (10--25)Red/552.5

Dogs in Treatment Group 3 ([Table I](#T1){ref-type="table"}) were treated with the appropriate size pipette of ADVANTIX^®^ spot-on for dogs (imidacloprid 10% w/v + permethrin 50% w/v). For treatment administration, the total volume was applied according to package instructions by parting the hair and applying directly on the skin in three spots along the midline from the top back of the shoulder blades to the base of the tail.

The *D. reticulatus* ticks used in this study were a laboratory strain, obtained from the ClinVet colony, free from known tick-borne pathogens and from a strain with no known resistance to any ectoparasiticide.

Dogs were infested with 50 *D. reticulatus* (50:50 sex ratio), for pre-treatment (Day -3) and for each subsequent infestation (Days 1, 7, 14, 21, 28 and 35). Each dog was sedated, and the ticks were gently deposited on the lateral aspect of the dog's chest. Any remaining ticks were counted 24 hours after each infestation.

All personnel involved with evaluation of efficacy were unaware of treatment status of dogs in the study. Personnel with access to the treatment assignments were identified prior to the first treatment being administered, and blinding was maintained throughout the study.

Specification of Study Variables {#S3}
--------------------------------

The ticks were categorized according to [Table II](#T2){ref-type="table"}. Categorization of the ticks allow calculation of the percent efficacy (killing effect), as well as the calculation of the attachment rate, in comparison with the untreated control group.Table II.Categorization of ticks for counting and interpretation.CategoryGeneral findingsAttachment statusInterpretation for prevention of attachmentInterpretation for killing effect (acaricidal)1LiveFreeDemonstratedNot demonstrated2LiveAttached; unengorgedNot demonstratedNot demonstrated3LiveAttached; engorged[1](#TFN1){ref-type="fn"}Not demonstratedNot demonstrated4DeadFreeDemonstratedDemonstrated5DeadAttached; unengorgedNot demonstratedDemonstrated6DeadAttached; engorged[1](#TFN1){ref-type="fn"}Not demonstratedNot demonstratedAdapted from [@R7].[^1]

Data Analysis {#S4}
-------------

To measure disruption of attachment rates, total counts of ticks in categories 2, 3, 5, and 6 ([Table II](#T2){ref-type="table"}), *i.e.* all "attached" categories (live or dead), were transformed to the natural logarithm of (count + 1) for calculation of geometric means by treatment group at each time point.

To measure the killing effect (% acaricidal efficacy), the total counts of adult ticks in categories 1 through 3 and 6 were transformed to the natural logarithm of (count + 1) for calculation of geometric means by treatment group at each time point. The ticks in the three "Live" categories, as well as in the "Dead, attached, engorged" category, were interpreted as treatment failures. Their counts were combined and the total for each dog was used in the subsequent analysis.

For both analysis, percent reduction from the negative control group (Treatment Group 1) mean was calculated for Treatment Groups 2 and 3, if applicable, at every post-treatment time point using the formula \[(C - T) / C\] × 100, where C is the geometric mean for the negative control group and T is the geometric mean for Treatment Group 2 or 3. Treatment Group 2 was compared to each of the other treatment groups (Treatment Groups 1 and 3) using Analysis of Variance on log count. All testing was two-sided at the significance level α = 0.05.

Results {#S5}
=======

Disruption of Attachment {#S6}
------------------------

The disruption of attachment is based on the counts of all attached ticks, live or dead, that are present at assessment, which in this study occurred at the 24-hour count ([Table III](#T3){ref-type="table"}, [Fig. 1](#F1){ref-type="fig"}) ([@R9]). The percentage of attachment at 24 hours was significantly higher (p \< 0.05) in the control group than in the treated groups at all time points. The rate of attachment was significantly lower (p \< 0.05) in the CERTIFECT^®^-treated group than the ADVANTIX^®^-treated group throughout the entire study. In the CERTIFECT^®^- treated group, 92.3% to 98.5% of ticks were prevented from attachment compared to the untreated group until Day 29. In the ADVANTIX^®^-treated group 54.7% to 78.4% of ticks were prevented from attachment compared to the untreated group until Day 29 ([Table III](#T3){ref-type="table"}). Fig 1.Disruption of attachment of *Dermacentor reticulatus* at 24-hour post-infestation. Table III.Geometric means of *Dermacentor reticulatus* ticks counts by category at 24-hour post-infestation and percent of disruption of attachment and percent killing efficacy at 24-hour counts.Categories 2, 3, 5 and 6Categories 1, 2, 3 and 6ControlCertifect^®^Advantix^®^ControlCertifect^®^Advantix^®^DayCnt.[1](#TFN2){ref-type="fn"}Cnt.%[2](#TFN3){ref-type="fn"}Cnt.%Cnt.Cnt.%Cnt.%223.461.2894.68.2664.8[\*](#TFN4){ref-type="fn"}23.030.1999.26.5071.88[\*](#TFN4){ref-type="fn"}824.751.2195.15.3478.423.420.00100.03.1186.78[\*](#TFN4){ref-type="fn"}1530.600.4598.59.9667.58[\*](#TFN4){ref-type="fn"}30.490.2299.38.9370.78[\*](#TFN4){ref-type="fn"}2233.432.5892.311.3066.28[\*](#TFN4){ref-type="fn"}33.181.5995.28.9073.28[\*](#TFN4){ref-type="fn"}2933.562.0294.015.1954.78[\*](#TFN4){ref-type="fn"}33.431.6595.114.6356.28[\*](#TFN4){ref-type="fn"}3629.376.3078.620.9229.38[\*](#TFN4){ref-type="fn"}29.466.5577.821.5627.38[\*](#TFN4){ref-type="fn"}[^2][^3][^4]

Speed of Kill {#S7}
-------------

The killing efficacy is shown on [Table III](#T3){ref-type="table"} and [Fig. 2](#F2){ref-type="fig"}. The fipronil/amitraz/(S)-methoprene efficacy at 24- hour counts was above 95% through the four weeks following treatment, decreasing to 77.8% following the Day 35 challenge. The imidacloprid/permethrin 24 hours efficacy did not reach 90% efficacy at any assessment throughout the study, with killing efficacy through the four weeks ranging from 56.2% to 86.7% at 24-hour counts. The difference between the two treatment groups was significant at all time points including Day 36.Fig 2.Comparative acaricidal efficacy at 24-hour tick counts.

Discussion {#S8}
==========

The tick counts in this study were conducted at 24 hours following each challenge, rather than 48 hours assessments. Previous studies have demonstrated that the efficacy of the imidacloprid/ permethrin combination at 48 hours is typically above 90% for three to four weeks or more, dependant upon the tick species studied ([@R4]; [@R6]; [@R12]). Another study performed against two tick species reported a rapid, but short-term activity of imidacloprid/permethrin causing a significant number of one of the tick species to remain unattached and repelled following infestation ([@R5]). The quicker a product acts, the lower the probability that a tick will initiate its blood feeding and transmit pathogens. Short-term rapid activity is important, but pets can be exposed to ticks throughout the treatment interval, not just in the days immediately following treatment. Therefore, the duration of that rapid activity is key. By 24 hours after each infestation the fipronil/amitraz/(S)-methoprene combination showed disruption of attachment \> 90% for a full month and efficacy \> 95% against *D. reticulatus* for a full month, demonstrating both a rapid and most importantly a consistent performance throughout the treatment period. Such consistency would be important for pet owners, who do not want to see engorged ticks on their dogs. Moreover, it is expected that the disruption of attachment and efficacy provided by 24 hours would reduce the risk of transmission of many pathogens transmitted by ticks.

[^1]: Engorged tick: a tick with a conspicuous enlargement of the alloscutum that has blood in its digestive tract, as shown by squeezing/ crushing of the tick on white paper.

[^2]: Cnt. = geometric mean tick count.

[^3]: \% = percent disruption of attachment at 24 hours for categories 2, 3, 5 and 6 or percent killing efficacy at 24-hour counts for categories 1, 2, 3 and 6.

[^4]: Significant difference between the two treatment groups at p \< 0.05.
